Abstract:Abstract:ObjectiveTo investigate the clinical outcome of microsurgery for parasagittal and parafalx meningioma in the middle cortex area, and summarize our surgical experience.MethodsClinical data of 40 patients with large parasagittal and parafalx meningioma in the middle cortex area hospitalized in our department from 2010 to 2015 were analyzed retrospectively.ResultsThe tumors were located in the middle cortex area, invading both the cerebral flax and sagittal sinus wall in 22 cases. Of them, Simpson grade I resection was achieved in 16 cases, and Simpson grade II resection in 6. Tumors were located in the middle cortex area and invaded cerebral flax and sagittal sinus cavity in 6. Of them, Simpson grade I resection was achieved in 4 cases with complete tumorinduced occlusion of the sinus cavity, and Simpson IV was achieved in 2 cases with incomplete occlusion of the sinus cavity. Simpson grade I resection was achieved in 5 cases with tumor invasion of cerebral flax only. Tumors were located in the middle cortex area and invaded sagittal sinus in 7 cases. Of them, tumor invaded the sinus wall in 5 and Simpson grade I/II resection was achieved in 3 and 2 cases respectively. For the 2 cases with tumor invasion of sagittal sinus cavity, Simpson grade IV resection was achieved. All the patients had been followed up for 3 months to 5 years postoperatively. 28 cases with Simpson I resection were completely cured. Among 8 cases with Simpson II resection, only one patient had tumor recurrence and was cured with gamma knife. One year after operation, the 4 cases with Simpson IV resection showed increase of residual tumor and were treated with gamma knife. All the 4 cases were lost to follow up. 10 patients experienced hemiplegia postoperatively. After one year of followup, 6 cases recovered completely and 4 recovered partially. No death occurred.ConclusionThe combination of venous sinus imaging and skilled microsurgical techniques can effectively protect the functional cortex structures and regurgitant veins, which can reduce intraoperative bleeding, improve the total resection rate, reduce disability and tumor recurrence rate and avoid death.